Developmental Research Program

发展研究计划

• 批准号: 7729512
• 负责人: COLIN P.N. DINNEY
• 金额: $ 11.45万
• 依托单位: UNIVERSITY OF TX MD ANDERSON CAN CTR
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-09-01 至 2011-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7729512
• 关键词: Cancer Center; Cisplatin; Collaborations; Development; Ensure; Environment; Frequencies; Funding; Genes; Genetic Determinism; Genetic Polymorphism; Genotype; Goals; Incidence; Invasive; Malignant neoplasm of urinary bladder; Metabolism; Multi-Drug Resistance; Muscle; Neoadjuvant Therapy; Nucleotide Excision Repair; Pathway interactions; Patients; Platinum; Proteins; Recurrence; Reproduction spores; Research; Scientist; Testing; Translational Research; analog; base; chemotherapy; drug metabolism; innovation; mortality; programs; response

The objectives of the Developmental Research Program are to: 1. Identify innovative projects with significant potential for reducing bladder cancer incidence and mortality and increasing survival. 2. Encourage collaborations among scientists within and outside the SPORE environment. 3. Develop specific criteria for selecting and funding projects. 4. Establish a mechanism to ensure Developmental Projects achieve their translational research goals.

发展研究计划的目标是： 1.确定具有显著降低膀胱癌发病率和死亡率潜力的创新项目 提高生存率。 2.鼓励SPORE环境内外的科学家之间的合作。 3.制定选择和资助项目的具体标准。 4.建立一个机制，以确保发展项目实现其转化研究目标。